Výsledky vyhledávání - "Jasper Koenders"

Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: The HOVON-87/NMSG-18 trial

Autor: Annemiek Broijl, Mark-David Levin, Annette W.G. van der Velden, Bronno van der Holt, Pieter Sonneveld, Martin H. van Vliet, Mark van Duin, Sonja Zweegman, H. Berna Beverloo, Jasper Koenders, Anders Waage, Marian Stevens-Kroef, Belinda Dumee, Markus Hansson, Rowan Kuiper, Michael Vermeulen, Heleen Visser-Wisselaar, Erik H. van Beers

Publikováno v: BLOOD ADVANCES, 4(24), 6298-6309. American Society of Hematology
Blood Adv
Kuiper, R, Zweegman, S, van Duin, M, van Vliet, M H, van Beers, E H, Dumee, B, Vermeulen, M, Koenders, J, van der Holt, B, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Berna Beverloo, H, Stevens-Kroef, M, Levin, M D, Broijl, A, Waage, A & Sonneveld, P 2020, ' Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma : The HOVON-87/NMSG-18 trial ', BLOOD ADVANCES, vol. 4, no. 24, pp. 6298-6309 . https://doi.org/10.1182/bloodadvances.2020002838
Blood Advances, 4, 24, pp. 6298-6309
Blood advances, 4(24), 6298-6309. American Society of Hematology
Blood Advances, 4, 6298-6309

The standard prognostic marker for multiple myeloma (MM) patients is the revised International Staging System (R-ISS). However, there is room for improvement in guiding treatment. This applies particularly to older patients, in whom the benefit/risk

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d91dfe1cea92994dc30642ab1625ba
https://research.vumc.nl/en/publications/2847a289-5ff2-4097-9696-709d941b5191

Zobrazit plný text záznamu

Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates

Autor: Peter J. M. Valk, Jan J. Cornelissen, Mathijs A. Sanders, Anita W. Rijneveld, Jasper Koenders, Judith M. Boer, Monique L. den Boer, Bronno van der Holt, Carla Exalto

Publikováno v: EUR Research Portal
Haematologica, 100. Ferrata Storti Foundation

Outcome in adult precursor B-cell acute lymphoblastic leukemia (BCP-ALL) is unsatisfactory, with complete response rates of approximately 80% and event-free survival at 5 years of only 40%–50%.[1][1] This inferior survival in adult compared with pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460401c471bb19fb51234a3373f2509b
https://doi.org/10.3324/haematol.2014.117424

Zobrazit plný text záznamu

Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations

Autor: Remco Hoogenboezem, Zabiollah G. Abbas, Wendy Mc C. Geertsma-Kleinekoort, Bob Löwenberg, Saman Abbas, Ellen van Drunen, Jasper Koenders, François G. Kavelaars, Souad Mahamoud, Justine K. Peeters, Annelieke Zeilemaker, Mathijs A. Sanders, H. Berna Beverloo, Peter J. M. Valk, Janneke F. van Galen, Isabel W. T. Chu

Publikováno v: Haematologica, 99(5), 848-857. Ferrata Storti Foundation

Acute myeloid leukemia is a neoplasm characterized by recurrent molecular aberrations traditionally demonstrated by cytogenetic analyses. We used high density genome-wide genotyping and gene expression profiling to reveal acquired cryptic abnormaliti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e31708eaa2ecc50b21662b8382208e1
https://doi.org/10.3324/haematol.2013.095604

Zobrazit plný text záznamu

Clonal Evolution of Multiple Myeloma in Patients from Diagnosis to First Relapse, Who Were Treated in Subsequent Clinical Trials

Autor: Annemiek Broijl, Kazem Nasserinejad, Remco Hoogenboezem, François G. Kavelaars, Mario Boccadoro, Pieter Sonneveld, Sonja Zweegman, Jasper Koenders, Peter J. M. Valk, Monique C. Minnema, Mark van Duin

Publikováno v: Blood. 134:1798-1798

Background Treatment of Multiple Myeloma (MM) has reached a point at which cure for a subset of patients becomes feasible. Still, resistance to therapy is a major challenge in the management of MM patients. Underlying resistance are the emergence of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1d618041f04c46b9a643c54b83edfdd5
https://doi.org/10.1182/blood-2019-130086

Zobrazit plný text záznamu

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value

Autor: Jasper Koenders, Anita M. Schelen, François G. Kavelaars, Anita W. Rijneveld, Wim J. L. van Putten, Bob Löwenberg, Sanne Lugthart, Peter J. M. Valk, Annelieke Zeilemaker, Saman Abbas

Publikováno v: Blood, 116(12), 2122-2126. American Society of Hematology

Somatic mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) were recently demonstrated in acute myeloid leukemia (AML), but their prevalence and prognostic impact remain to be explored in large extensively characterized AML series, and also

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de5d9c6e9caf520d0b48e615fe977606
https://doi.org/10.1182/blood-2009-11-250878

Zobrazit plný text záznamu

Extensive RAG-Mediated Rearrangements and Mutations in BCR-ABL1 and BCR-ABL1-like Adult Acute Lymphoblastic Leukemia

Autor: Annelieke Zeilemaker, Jasper Koenders, Anita M. Schelen, H. Berna Beverloo, Anikó Szabó, Peter J. M. Valk, Carla Exalto, Anita W. Rijneveld, Jan J. Cornelissen, Peter van Geel, Mathijs A. Sanders, Remco Hoogenboezem

Publikováno v: Blood. 128:4067-4067

BCR-ABL1 and BCR-ABL1-like acute lymphoblastic leukemia (ALL) are two major pre-B cell acute leukemia subtypes characterized by genetic alterations affecting lymphoid-specific transcription factors. Studies examining the chain of genetic events neces

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1427cf1e45cd9289bd4706d47e07250d
https://doi.org/10.1182/blood.v128.22.4067.4067

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání